Yifeng Pharmacy Financials
| 603939 Stock | 22.56 1.40 5.84% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 2.2 B | 2.1 B |
|
|
Yifeng | Select Account or Indicator |
Understanding current and past Yifeng Pharmacy Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Yifeng Pharmacy's financial statements are interrelated, with each one affecting the others. For example, an increase in Yifeng Pharmacy's assets may result in an increase in income on the income statement.
Please note, the presentation of Yifeng Pharmacy's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Yifeng Pharmacy's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Yifeng Pharmacy's management manipulating its earnings.
Yifeng Pharmacy Stock Summary
Yifeng Pharmacy competes with Holitech Technology, Sunwave Communications, Kuangda Technology, Hubei Yingtong, and Tianshui Huatian. Yifeng Pharmacy is entity of China. It is traded as Stock on SHG exchange.Specialization | Consumer Staples, Consumer Staples Distribution & Retail |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100001TS5 |
| Business Address | No68, Jinzhou Avenue, |
| Sector | Consumer Staples Distribution & Retail |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.yfdyf.cn |
| Phone | 86 73 1858 63086 |
You should never invest in Yifeng Pharmacy without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Yifeng Stock, because this is throwing your money away. Analyzing the key information contained in Yifeng Pharmacy's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Yifeng Pharmacy Key Financial Ratios
Yifeng Pharmacy's financial ratios allow both analysts and investors to convert raw data from Yifeng Pharmacy's financial statements into concise, actionable information that can be used to evaluate the performance of Yifeng Pharmacy over time and compare it to other companies across industries.| Revenue | 22.59 B | ||||
| Gross Profit | 7.8 B | ||||
| EBITDA | 2.36 B | ||||
| Net Income | 1.41 B | ||||
| Total Asset | 24.14 B |
Yifeng Pharmacy Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 9.2B | 12.9B | 17.1B | 21.0B | 24.1B | 25.3B | |
| Other Current Liab | 321.2M | 525.1M | 672.4M | 1.0B | 22.6M | 21.5M | |
| Other Liab | 54.1M | 53.9M | 52.5M | 78.4M | 90.2M | 48.4M | |
| Accounts Payable | 3.0B | 3.8B | 4.8B | 6.8B | 8.2B | 8.6B | |
| Cash | 1.4B | 3.4B | 2.9B | 4.1B | 3.6B | 3.7B | |
| Other Assets | 239.8M | 400.0M | 517.8M | 568.5M | 653.7M | 686.4M | |
| Net Receivables | 953.0M | 830.3M | 1.1B | 1.8B | 2.1B | 2.2B | |
| Inventory | 1.8B | 2.2B | 3.0B | 3.6B | 3.8B | 4.0B | |
| Other Current Assets | 547.5M | 341.7M | 356.7M | 466.0M | 384.1M | 298.8M | |
| Total Liab | 4.5B | 7.2B | 9.2B | 11.9B | 13.7B | 14.4B | |
| Intangible Assets | 355.1M | 375.3M | 396.5M | 485.5M | 474.5M | 271.2M | |
| Common Stock | 378.9M | 531.5M | 718.8M | 721.7M | 830.0M | 871.5M | |
| Retained Earnings | 1.5B | 2.1B | 2.8B | 3.9B | 4.8B | 5.0B | |
| Good Will | 3.0B | 3.3B | 3.7B | 4.2B | 4.6B | 2.6B | |
| Net Tangible Assets | 1.1B | 1.7B | 3.4B | 3.9B | 4.5B | 2.3B | |
| Total Current Assets | 5.0B | 7.7B | 7.9B | 10.6B | 12.1B | 6.8B | |
| Net Invested Capital | 5.2B | 7.8B | 7.8B | 8.8B | 9.9B | 7.5B | |
| Net Working Capital | 1.3B | 2.9B | 1.2B | 918.9M | 859.4M | 1.2B | |
| Long Term Debt | 687.2M | 2.0B | 365.6M | 228.7M | 133.6M | 126.9M | |
| Capital Stock | 378.9M | 531.5M | 718.8M | 721.7M | 1.0B | 685.4M |
Yifeng Pharmacy Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 45.8M | 78.5M | 169.0M | 165.2M | 160.5M | 168.6M | |
| Total Revenue | 10.3B | 13.1B | 15.3B | 19.9B | 22.6B | 23.7B | |
| Operating Income | 840.4M | 1.2B | 1.5B | 2.0B | 2.1B | 2.2B | |
| Cost Of Revenue | 6.3B | 8.2B | 9.1B | 12.0B | 14.0B | 14.7B | |
| Income Before Tax | 814.3M | 1.2B | 1.3B | 1.9B | 2.0B | 2.1B | |
| Net Income | 543.8M | 768.3M | 887.9M | 1.3B | 1.4B | 1.5B | |
| Income Tax Expense | 205.4M | 287.9M | 347.2M | 450.3M | 517.8M | 543.7M | |
| Minority Interest | 200.7M | 313.4M | (102.9M) | (161.6M) | (168.9M) | (160.5M) | |
| Gross Profit | 4.0B | 5.0B | 6.2B | 7.9B | 8.6B | 4.8B | |
| Ebit | 830.5M | 1.2B | 1.4B | 1.9B | 2.2B | 2.3B | |
| Tax Provision | 205.4M | 297.1M | 347.2M | 450.3M | 456.7M | 286.7M | |
| Net Interest Income | (38.5M) | (34.0M) | (114.9M) | (104.8M) | (86.2M) | (81.9M) | |
| Interest Income | 22.1M | 58.5M | 64.1M | 73.2M | 93.3M | 49.0M | |
| Ebitda | 954.8M | 1.4B | 2.7B | 3.5B | 4.0B | 4.2B |
Yifeng Pharmacy Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Yifeng Pharmacy. It measures of how well Yifeng is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Yifeng Pharmacy brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Yifeng had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Yifeng Pharmacy has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Dividends Paid | 157.5M | 164.0M | 211.9M | 235.0M | 321.9M | 338.0M | |
| Capital Expenditures | 459.3M | 582.8M | 827.5M | 587.5M | 739.9M | 372.8M | |
| Net Income | 543.8M | 768.3M | 887.9M | 1.3B | 1.4B | 1.5B | |
| Change To Inventory | (300.5M) | (342.1M) | (885.1M) | (459.4M) | (261.5M) | (274.6M) | |
| Investments | 53.0M | (531.0M) | 681.0M | (241.0M) | (3.0B) | (2.8B) | |
| Change In Cash | (47.8M) | 1.8B | (601.9M) | 991.0M | (449.6M) | (427.1M) | |
| Net Borrowings | (28.2M) | 865.5M | (704.5M) | (1.4B) | (1.3B) | (1.2B) | |
| Depreciation | 94.7M | 941.9M | 1.2B | 1.4B | 1.6B | 1.7B | |
| Change To Netincome | 121.3M | 296.4M | 175.1M | 373.6M | 429.6M | 451.1M | |
| End Period Cash Flow | 741.2M | 2.5B | 1.9B | 2.9B | 2.5B | 1.6B | |
| Free Cash Flow | 509.2M | 752.9M | 1.3B | 3.3B | 3.9B | 4.1B | |
| Other Non Cash Items | 141.6M | 180.7M | 286.9M | 310.6M | 343.5M | 219.0M |
Yifeng Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Yifeng Pharmacy's current stock value. Our valuation model uses many indicators to compare Yifeng Pharmacy value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Yifeng Pharmacy competition to find correlations between indicators driving Yifeng Pharmacy's intrinsic value. More Info.Yifeng Pharmacy is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.35 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Yifeng Pharmacy is roughly 2.88 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Yifeng Pharmacy by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Yifeng Pharmacy's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Yifeng Pharmacy Systematic Risk
Yifeng Pharmacy's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Yifeng Pharmacy volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Yifeng Pharmacy correlated with the market. If Beta is less than 0 Yifeng Pharmacy generally moves in the opposite direction as compared to the market. If Yifeng Pharmacy Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Yifeng Pharmacy is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Yifeng Pharmacy is generally in the same direction as the market. If Beta > 1 Yifeng Pharmacy moves generally in the same direction as, but more than the movement of the benchmark.
Yifeng Pharmacy Total Assets Over Time
Yifeng Pharmacy November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Yifeng Pharmacy help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Yifeng Pharmacy. We use our internally-developed statistical techniques to arrive at the intrinsic value of Yifeng Pharmacy based on widely used predictive technical indicators. In general, we focus on analyzing Yifeng Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Yifeng Pharmacy's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.32 | |||
| Information Ratio | 0.0253 | |||
| Maximum Drawdown | 20.99 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 9.49 |
Complementary Tools for Yifeng Stock analysis
When running Yifeng Pharmacy's price analysis, check to measure Yifeng Pharmacy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Yifeng Pharmacy is operating at the current time. Most of Yifeng Pharmacy's value examination focuses on studying past and present price action to predict the probability of Yifeng Pharmacy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Yifeng Pharmacy's price. Additionally, you may evaluate how the addition of Yifeng Pharmacy to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |